Varex Imaging (VREX) Cash from Investing Activities (2016 - 2026)
Varex Imaging's (VREX) quarterly Cash from Investing Activities came in at -$3.1 million in Q2 2026, down 121.09% year-on-year from $14.7 million in Q2 2025, and up 59.74% on a QoQ basis from -$7.7 million in Q1 2026.
Varex Imaging (VREX) Cash from Investing Activities (2016 - 2026) Analysis & Trends
Varex Imaging (VREX) has 11 years of Cash from Investing Activities data on file, last reported at -$3.1 million in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 121.09% year-over-year to -$3.1 million in Q2 2026; TTM through Apr 2026 was -$12.2 million, a 325.93% decrease from a year earlier, with the FY2025 full-year figure at $10.3 million, up 137.45% from the prior year.
- Cash from Investing Activities for Q2 2026 stood at -$3.1 million, up from -$7.7 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for VREX reached as high as $14.7 million in Q2 2025 and fell as low as -$27.5 million in Q3 2022.
- Historically, Cash from Investing Activities has averaged -$7.0 million across 5 years, with a median of -$3.8 million in 2023.
- Across the five-year window, Cash from Investing Activities sank 733.33% in 2022 and surged 1230.77% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$3.7 million in 2022, then sank by 437.84% to -$19.9 million in 2023, then climbed by 29.65% to -$14.0 million in 2024, then soared by 95.0% to -$700000.0 in 2025, then plunged by 342.86% to -$3.1 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$3.1 million in Q2 2026, -$7.7 million in Q1 2026, and -$700000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Varex Imaging | 458.64 Mn | 370.34 Mn | 72.60 Mn | -3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -3.10 Mn |
| Apr 3, 2026 | -3.10 Mn |
| Jan 2, 2026 | -7.70 Mn |
| Jan 2, 2026 | -7.70 Mn |
| Oct 3, 2025 | -700,000.00 |
| Oct 3, 2025 | -700,000.00 |
| Jul 4, 2025 | -700,000.00 |
| Jul 4, 2025 | -700,000.00 |
| Apr 4, 2025 | 14.70 Mn |
| Apr 4, 2025 | 14.70 Mn |
| Jan 3, 2025 | -3.00 Mn |
| Jan 3, 2025 | -3.00 Mn |
| Sep 27, 2024 | -14.00 Mn |
| Sep 27, 2024 | -14.00 Mn |
| Jun 28, 2024 | 7.70 Mn |
| Jun 28, 2024 | 7.70 Mn |
| Mar 29, 2024 | -1.30 Mn |
| Mar 29, 2024 | -1.30 Mn |
| Dec 29, 2023 | -19.90 Mn |
| Dec 29, 2023 | -19.90 Mn |